Radiopharmaceuticals Market involves radioactive drugs used for diagnosis and treatment of diseases, especially cancer and neurological disorders. The Radiopharmaceuticals Market is rapidly growing, ...

The global monoclonal antibodies market is poised for robust expansion, projected to surge from USD 208.32 billion in 2022 to USD 647.01 billion by 2032, reflecting a CAGR of 12% over the forecast ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

The “ Acute Myocardial Infarction Market Report ” by DelveInsight offers a robust analysis of market size, treatment ...

Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential deal value above $1.3 billion.

IntroductionGestational diabetes (GD) is a condition that occurs during pregnancy, where a woman without diabetes develops high blood sugar levels. The condition typically appears in the second or ...

The chronic pruritus market is expected to grow across the 7MM, driven by the introduction of innovative therapies like ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

This partnership, which officials said has the potential to be the largest ever U.S. industry-academic agreement of its kind, ...

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 30 unusual trades. Delving into the details, we found 50% of ...

Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. The Trump ...